Hilliard Marisa E, Levy Wendy, Weinstock Ruth S, Hood Korey K, Trief Paula M, DeSalvo Daniel J, Rojas Yuliana, Holland Kyrah, Schneider-Utaka Aika K, Alamarie Selma A, Agostini Lynn, Kim Se-Kang, de Wit Maartje, McGrady Meghan E, Messer Laurel H, Anderson Barbara J
Baylor College of Medicine, Department of Pediatrics, USA.
Texas Children's Hospital, USA.
Contemp Clin Trials Commun. 2025 May 13;45:101491. doi: 10.1016/j.conctc.2025.101491. eCollection 2025 Jun.
Type 1 diabetes (T1D) management is demanding and can impact quality of life among persons with diabetes (PWDs) and their family members. Behavioral intervention research has largely focused on adolescents, and previous interventions that have benefitted quality of life have limited potential for implementation in routine care. This trial is piloting a brief behavioral intervention that targets health-related quality of life (HRQOL), which can be implemented with PWDs of all ages in a range of clinical care settings. The aims are to (1) evaluate intervention feasibility and acceptability, (2) explore pre-post change in psychosocial and clinical outcomes, and (3) explore costs related to intervention development and implementation.
Participants are PWD of all ages who receive T1D care in pediatric subspecialty, adult specialty, and primary care settings (target n = 120, 40/site) and a parent (for children) or partner (for adults). Certified diabetes care and education specialists deliver the intervention during two ∼30-45-min remote sessions over 6 months. In the sessions, interventionists review a "quality of life profile" generated from participants' pre-session responses to a measure of T1D-specific HRQOL, and provide behavioral strategies and resources tailored to their individual strengths and challenges. Feasibility and acceptability data include recruitment/enrollment/retention rates, intervention fidelity, satisfaction surveys, and qualitative interviews. Pre-post measures of psychosocial and clinical outcomes are collected at baseline and 6 months.
This pilot study will generate preliminary data about a brief intervention targeting HRQOL for youth and adult PWDs and family members, designed for implementation across a range of care settings.
1型糖尿病(T1D)的管理要求很高,会影响糖尿病患者(PWDs)及其家庭成员的生活质量。行为干预研究主要集中在青少年身上,以往那些对生活质量有益的干预措施在常规护理中的实施潜力有限。本试验正在试点一项针对健康相关生活质量(HRQOL)的简短行为干预,该干预可在一系列临床护理环境中应用于所有年龄段的PWDs。目的是:(1)评估干预的可行性和可接受性;(2)探索心理社会和临床结果的前后变化;(3)探索与干预开发和实施相关的成本。
参与者为在儿科专科、成人专科和初级护理机构接受T1D护理的所有年龄段的PWDs,以及儿童的家长(对于儿童)或成人的伴侣。认证糖尿病护理和教育专家在6个月内通过两次约30 - 45分钟的远程会议提供干预。在会议中,干预人员会查看根据参与者对T1D特定HRQOL测量的会前回答生成的“生活质量概况”,并提供针对其个人优势和挑战的行为策略和资源。可行性和可接受性数据包括招募/登记/保留率;干预保真度;满意度调查;以及定性访谈。在基线和6个月时收集心理社会和临床结果的前后测量数据。
这项试点研究将生成关于一项针对青少年和成人PWDs及其家庭成员的HRQOL简短干预的初步数据,该干预旨在在一系列护理环境中实施。